Expertise in
6
conditions

Dr. Dennis E. Hallahan

Radiation Oncology
Ausam Corp Chartered
6 Memorial Dr, 
Alton, IL 
Accepting New Patients
Expertise in
6
conditions
Ausam Corp Chartered
6 Memorial Dr, 
Alton, IL 

Overview

Dennis Hallahan is a Radiation Oncologist practicing medicine in Alton, Illinois.

Dr. Hallahan is highly rated in 6 conditions, according to our data. His clinical expertise encompasses Astrocytoma, Glioblastoma, Glioma, and Gliomatosis Cerebri.

He is actively involved in clinical research, co-authoring 59 peer reviewed articles and participating in 6 clinical trials. Dr. Hallahan is currently accepting new patients.

Specialties

Radiation Oncology

Licenses

Radiology in MO

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Cox Health
  • EPO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Meridian Choice
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
View 5 Less Insurance Carriers -

Locations

Ausam Corp Chartered
6 Memorial Dr, Alton, IL 62002

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

A Trial of Palliative Lattice Stereotactic Body Radiotherapy (SBRT) for Patients With Sarcoma, Thoracic, Abdominal, and Pelvic Cancers
A Trial of Palliative Lattice Stereotactic Body Radiotherapy (SBRT) for Patients With Sarcoma, Thoracic, Abdominal, and Pelvic Cancers
Enrollment Status: Completed
Publish Date: August 29, 2024
Intervention Type: Radiation, Procedure
Study Phase: Not Applicable
A Phase IB Study to Use Tadalafil to Overcome Immunosuppression During Chemoradiotherapy for IDH-wildtype Grade III-IV Astrocytoma
A Phase IB Study to Use Tadalafil to Overcome Immunosuppression During Chemoradiotherapy for IDH-wildtype Grade III-IV Astrocytoma
Enrollment Status: Completed
Publish Date: June 13, 2023
Intervention Type: Drug
Study Drug: Tadalafil
Study Phase: Phase 1
A Trial of Palliative Lattice Stereotactic Body Radiotherapy (SBRT)
A Trial of Palliative Lattice Stereotactic Body Radiotherapy (SBRT)
Enrollment Status: Completed
Publish Date: November 22, 2021
Intervention Type: Radiation, Procedure
Study Phase: Not Applicable
Objective Treatment Allocation With SBRT vs. Surgery in High Risk Patients With Early Stage Lung Cancer Within an Accountable Care Collaborative Effort Between Surgery and Radiation Oncology
Objective Treatment Allocation With SBRT vs. Surgery in High Risk Patients With Early Stage Lung Cancer Within an Accountable Care Collaborative Effort Between Surgery and Radiation Oncology
Enrollment Status: Completed
Publish Date: April 08, 2021
Intervention Type: Behavioral
Study Phase: Not Applicable
A Phase I Trial of Lattice Stereotactic Body Radiation Therapy (Lattice SBRT) for Localized Unresectable or Metastatic Conventional Type Chondrosarcoma
A Phase I Trial of Lattice Stereotactic Body Radiation Therapy (Lattice SBRT) for Localized Unresectable or Metastatic Conventional Type Chondrosarcoma
Enrollment Status: Withdrawn
Publish Date: September 16, 2020
Intervention Type: Radiation
Study Phase: Not Applicable
Phase I/II Trial of Lithium as a Neuroprotective Agent for Patients With Small Cell Lung Cancer (SCLC) Treated With Prophylactic Cranial Irradiation (PCI)
Phase I/II Trial of Lithium as a Neuroprotective Agent for Patients With Small Cell Lung Cancer (SCLC) Treated With Prophylactic Cranial Irradiation (PCI)
Enrollment Status: Completed
Publish Date: July 05, 2018
Intervention Type: Radiation, Drug
Study Phase: Phase 1/Phase 2
View 5 Less Clinical Trials

59 Total Publications

Blocking the functional domain of cancer cell surface TIP1 upregulates Midkine via the β-catenin/Wnt signaling pathway.
Blocking the functional domain of cancer cell surface TIP1 upregulates Midkine via the β-catenin/Wnt signaling pathway.
Journal: Cancer gene therapy
Published: December 19, 2023
Similar Doctors
Expertise in
15
conditions
Dr. Perry W. Grigsby
Radiation Oncology
Expertise in
15
conditions
Dr. Perry W. Grigsby
Radiation Oncology
Referral may be required

Barnes Hospital Washington University

510 S Kingshighway Blvd, 
Saint Louis, MO 
 (19.0 miles away)
Languages Spoken:
English
See accepted insurances

Perry Grigsby is a Radiation Oncologist practicing medicine in Saint Louis, Missouri. Dr. Grigsby is highly rated in 15 conditions, according to our data. His clinical expertise encompasses Cervical Cancer, Thyroid Cancer, Papillary Thyroid Cancer, Follicular Thyroid Cancer, and Thyroidectomy.

Expertise in
26
conditions
Dr. Clifford G. Robinson
Radiation Oncology
Expertise in
26
conditions
Dr. Clifford G. Robinson
Radiation Oncology
Referral may be required

Washington University School Of Medicine

4921 Parkview Pl, 
Saint Louis, MO 
 (18.8 miles away)
314-747-7236
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Clifford Robinson is a Radiation Oncologist practicing medicine in Saint Louis, Missouri. Dr. Robinson is highly rated in 26 conditions, according to our data. His clinical expertise encompasses Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC), and Pleuropulmonary Blastoma. Dr. Robinson is currently accepting new patients.

Expertise in
6
conditions
Dr. Jeff M. Michalski
Radiation Oncology
Expertise in
6
conditions
Dr. Jeff M. Michalski
Radiation Oncology
Referral may be required

Washington University School Of Medicine

4921 Parkview Pl, 
Saint Louis, MO 
 (18.8 miles away)
314-747-7236
Languages Spoken:
English, French
See accepted insurances
Accepting New Patients

Jeff Michalski is a Radiation Oncologist practicing medicine in Saint Louis, Missouri. Dr. Michalski is highly rated in 6 conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Familial Prostate Cancer, Muscle Invasive Bladder Cancer, Angiosarcoma, and Prostatectomy. Dr. Michalski is currently accepting new patients.

Frequently Asked Questions about Dr. Dennis E. Hallahan

Is Dr. Dennis E. Hallahan a top-rated expert for Astrocytoma?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Dennis E. Hallahan is classified as an Distinguished expert for Astrocytoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Dennis E. Hallahan specialize in?

While Dr. Dennis E. Hallahan is a Radiation Oncology, they have specific expertise in Astrocytoma, Glioblastoma, and Glioma. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Radiation Oncology.

Does Dr. Dennis E. Hallahan participate in research or clinical trials?

Yes. Dr. Dennis E. Hallahan has published 59 articles and abstracts on conditions like Astrocytoma. You can view a list of Dr. Dennis E. Hallahan's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Dennis E. Hallahan accept my insurance?

Dr. Dennis E. Hallahan accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Hallahan's expertise for a condition
ConditionClose
    View All 23 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile